钙化性主动脉瓣狭窄的多系统共病与共享遗传通路:全表型组与孟德尔随机化分析
基于英国生物银行467 484名参与者的观察性与多基因全表型组关联研究,评估钙化性主动脉瓣狭窄(CAS)与1571种表型的关联,并用基于FinnGen的22个CAS相关变异行两样本孟德尔随机化。结果显示CAS与42种心血管及非心血管疾病风险升高相关,多数关联在去除LPA变异或校正血浆Lp(a)后失去显著性,提示LPA/Lp(a)介导的共享遗传通路。
要点
- CAS伴随广泛的代谢、内分泌、血液及呼吸系统共病负担
- 循环与代谢疾病在CAS病程轨迹中通常先于其他共病出现
- LPA变异与Lp(a)水平是连接瓣膜钙化与多系统疾病的关键通路
核心结论
- CAS嵌入广泛的多系统共病网络,主要由LPA遗传变异和Lp(a)升高驱动,支持LPA靶向治疗作为减轻CAS多系统负担的潜在途径。
研究设计与样本
- 英国生物银行467 484名参与者的观察性与多基因全表型组关联研究,覆盖1571种表型,并整合疾病轨迹分析。
- 对观察性与多基因分析均复现的关联,基于FinnGen的22个CAS相关变异行两样本孟德尔随机化。
- 行多基因风险评分分析并排除特定基因,评估其贡献,重点关注LPA与血浆脂蛋白(a)水平。
主要发现
- CAS与42种心血管和非心血管疾病风险升高相关,以代谢、内分泌、血液和呼吸系统疾病最为突出。
- 时间分析显示,循环与代谢疾病在CAS轨迹中通常先于其他共病出现。
- 孟德尔随机化结果支持CAS对多种心血管疾病、缺铁性贫血、精神障碍和胸腔积液的因果效应。
- 从CAS多基因风险评分中去除LPA变异或校正血浆Lp(a)浓度后,多数关联失去显著性,提示共享的LPA/Lp(a)介导遗传通路。
临床怎么用
- 对CAS患者应关注代谢、内分泌、血液和呼吸系统共病,并按病程轨迹早期识别循环与代谢疾病。
- Lp(a)与LPA变异可能成为评估CAS多系统负担及LPA靶向治疗的潜在切入点。
局限性
- 研究基于英国生物银行人群,结论外推需谨慎。
- 孟德尔随机化基于FinnGen的22个CAS相关变异,因果推断受工具变量与人群差异限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Calcific aortic stenosis (CAS) is frequently accompanied by systemic comorbidities, but their causal relationships and shared genetic architecture remain poorly defined. We aimed to map the multisystem comorbidity network of CAS and clarify underlying genetic mechanisms. METHODS: In 467 484 participants from the UK Biobank, observational and polygenic phenome-wide association studies evaluated associations between CAS and 1571 phenotypes, integrating disease-trajectory analyses to visualise temporal patterns. Associations replicated across observational and polygenic analyses were tested using two-sample Mendelian randomisation (MR) based on 22 CAS-related variants from FinnGen. Polygenic risk score (PRS) analyses excluding specific genes assessed their contributions, particularly LPA and plasma lipoprotein(a) (Lp(a)) levels. RESULTS: CAS was associated with higher risks of 42 cardiovascular and non-cardiovascular conditions, most prominently metabolic, endocrine, haematological and respiratory disorders. Temporal analyses showed that circulatory and metabolic diseases typically precede other comorbidities in CAS trajectories. MR findings were consistent with causal effects of CAS on multiple cardiovascular diseases, iron-deficiency anaemia, mental disorders and pleural effusion. When LPA variants were removed from the CAS PRS or plasma Lp(a) concentration was adjusted for, most associations lost significance, indicating a shared LPA/Lp(a)-mediated genetic pathway. CONCLUSIONS: CAS is embedded within a broad multisystem comorbidity network, driven largely by genetic variation at LPA and elevated Lp(a). These findings highlight pleiotropic mechanisms linking valvular calcification with systemic disease and support LPA-targeted therapies as a promising avenue for reducing the multisystem burden of CAS.
引用
- Zhou Z, Zheng Y, Hu S, et al. Multisystem comorbidities and shared genetic pathways in calcific aortic stenosis: a phenome-wide and Mendelian randomisation analysis. Heart. 2026. PMID: 41461542. doi:10.1136/heartjnl-2025-326058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。